Esperion Theraptc (ESPR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 51,632 | 73,834 | 137,735 | 32,250 | 33,969 |
| Cost of Goods | 17,286 | 15,609 | 10,075 | 11,452 | 13,377 |
| Gross Profit | 34,346 | 58,225 | 127,660 | 20,798 | 20,592 |
| Operating Expenses | 50,658 | 56,255 | 55,466 | 63,617 | 48,502 |
| Operating Income | -16,026 | 2,579 | 72,269 | -42,367 | -27,533 |
| Interest Expense | 15,082 | 13,723 | 14,024 | 15,057 | 14,995 |
| Other Income | 1,584 | -50,781 | 2,777 | 1,080 | 1,278 |
| Pre-tax Income | -29,524 | -61,925 | 61,022 | -56,344 | -41,250 |
| Net Income Continuous | -29,524 | -61,925 | 61,022 | -56,344 | -41,250 |
| Net Income | $-29,524 | $-61,925 | $61,022 | $-56,344 | $-41,250 |
| EPS Basic Total Ops | -0.15 | -0.33 | 0.36 | -0.41 | -0.37 |
| EPS Basic Continuous Ops | -0.15 | -0.33 | 0.36 | -0.42 | -0.37 |
| EPS Diluted Total Ops | -0.15 | -0.33 | 0.34 | -0.41 | -0.37 |
| EPS Diluted Continuous Ops | -0.15 | -0.33 | 0.32 | -0.42 | -0.37 |
| EPS Diluted Before Non-Recurring Items | -0.15 | -0.05 | 0.34 | N/A | N/A |
| EBITDA(a) | $-15,553 | $3,031 | $72,706 | $-41,930 | $-27,080 |